|
|
Article: The Value of Serbia's Pharmaceuticals and Healthcare Market Is Expected to Top RSD113.77 US$1.69bn in 2013.
- Article from:
- Biotech Week
- Article date:
- October 14, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Research and Markets (http://www.researchandmarkets.com/research/0b4072/serbia_pharmaceuti) has announced the addition of the "Serbia Pharmaceuticals and Healthcare Report Q4 2009" report to their offering (see also Research and Markets).
This Serbia Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with independent forecasts and competitive intelligence on Serbia's pharmaceuticals and healthcare industry
In the Q409 Business Environment Rating (BER) matrix, Serbia continued to improve its placement, and is now found in 9th ...